|

|

ABOUT
Company Profile Management Team Message from the CEO Corporate Culture Company History Honors and Awards

Over 17 years of experience in R&DLearn more
CLIENT CENTER
Intellectual Property Protection Downloads Partnerships Pharma Updates

Global

U.S.

Address: 1 Broadway, Cambridge, MA02142 (America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369
News
Medicilon Events Featured Stories Market Events Videos

2022-01-04 Medicilon Events

Sincere Collaboration, New and Far-Reaching - Bao Pharmaceutical and Medicilon reached a strategic collaboration

On December 17, 2021, Shanghai Bao Pharmaceutical Co., Ltd. (Bao) and Shanghai Medicilon Inc. (Medicilon) signed an innovative drug IND R&D service strategy collaboration agreement.

Learn more

2022-01-04 Featured Stories

Medicilon Bacterial Endotoxin Testing Solutions

Bacterial Endotoxin Test Procedure Bacterial endotoxin method development (sample volume 3 bottles/batch, one batch) Bacterial endotoxin method verification (sample volume 3 bottles/batch, three batches) Bacterial endotoxin test (sample volume 3 bottles/batch, three batches) Bacterial endotoxin is one of the components of the cell wall of Gram-negative bacteria: LPS Released after the bacteria die Bacterial endotoxinRead more

Learn more
INVESTORS
Stock Information Investment Contact

Medicilon

688202

370.00

RMB

-19.40 （ -4.97 %）

As of

2022-01-23 14:44

Beijing time

The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com
CAREERS
Talent Development Employee Activities Campus Recruitment Social Recruitment

Campus Recruitment

Campus Recruitment

Social Recruitment

Social Recruitment

© 2021 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 |Website Map

Close

ABOUT
Company Profile Management Team Honors and Awards Corporate Culture

SERVICES
Drug Discovery Pharmaceutical Research Preclinical Research

PLATFORM
One-stop Integrated Services Key Technical Services for Drug R&D Innovative Drug R&D Services Drug Efficacy Evaluation for Common Diseases Advanced Preparation R&D

CLIENT CENTER
Intellectual Property Protection Downloads Partnerships Pharma Updates

NEWS
Medicilon Events Featured Stories Market Events Videos

INVESTORS
Stock Information Investment Contact

CAREERS
Talent Development Employee Activities Campus Recruitment Social Recruitment

© 2021 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 |Website Map

Close

Business Inquiry

Global：

Email:marketing@medicilon.com

+1(626)986-9880(U.S. - West Coast)

0044 7790 816 954 (Europe)

China：

Email: marketing@medicilon.com.cn

Tel: +86 (21) 5859-1500

Online Message×

Containneurological-disordersContent

Service（1）News（76）

Research on IL-33 in central nervous system diseases

Some neurological diseases are seriously plaguing people’s lives and affecting people’s health. The lack of suitable animal models that can truly reproduce the pathology and characteristics of human diseases also severely restricts the understanding of disease mechanisms. Central nervous system disease models are of great significance for studying the pathogenesis of central nervous system diseasesRead more

Immunotherapeutic Antibody Helps Prevent Neurodegeneration

Scientists from the Gladstone Institutes say they developed an antibody that blocks the inflammatory and oxidative activity of fibrin, which contributes to neurodegeneration in the brain, without compromising the protein’s clotting function. To come up with a precise and highly effective antibody, the researchers focused on targeting only a small region of the fibrin protein thatRead more

Family Genetics Key to Severity of Autism and Other Neurodevelopmental Disorders

Techniques such as high-throughput genome sequencing have allowed scientists to identify hundreds of genetic variants that are linked with increased risk of different neurodevelopmental or neuropsychological disorders, such epilepsy, schizophrenia, intellectual disability, and autism spectrum disorder (ASD). However, two people with the same known risk variant won’t necessarily present with the same symptoms. ARead more

MS Drug Slows Brain Shrinkage by Nearly Half

A team led by researchers from the Cleveland Clinic’s Neurological Institute reports that a promising drug slowed brain shrinkage in progressive multiple sclerosis (MS) by nearly half. Limited therapies are currently available for this disabling form of the disease, according to the scientists. The definitive results of the Phase II trial (“Phase 2Read more

New Brain Cell Has Unique Shape, Behavior, Gene Signature

Two research teams – one focused on gene expression, the other on cell shape and behavior – converged on a previously unknown type of brain cell. Because it resembles a rose deprived of its petals, the newly discovered brain cell has been called the “rosehip neuron.” Intriguingly, it may be unique to human brains, orRead more

Transport Protein Study May Lead to New Therapies for Psychiatric Disorders

Researchers at the Columbia University Irving Medical Center (CUIMC) have found new evidence of how certain transport proteins are working at the molecular level, paving the way for new, improved drugs to treat psychiatric disorders. Their study (“The LeuT-fold neurotransmitter:sodium symporter MhsT has two substrate sites”) is published in PNAS. “Crystal structures of the neurotransmitter:sodiumRead more

Parkinson’s Symptoms Associated with Contact Sports

In recent years awareness about the neurological risks associated with playing contact sports has risen exponentially. This increased mindfulness stems from the mounting evidence that repetitive head impacts from contact sports and other exposures are associated with the neurodegenerative disease chronic traumatic encephalopathy (CTE) and dementia. Now, new data from a team of investigators atRead more

Fragile X Symptoms May be Helped with New Pharmacological Approach

Scientists report that a pharmacological strategy can alleviate multiple behavioral and cellular deficiencies in a mouse model of fragile X syndrome (FXS), the most common inherited form of intellectual disability and a major single-gene cause of autism spectrum disorders. The study (“Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in aRead more

Artificial Human Prions Created in the Lab

Brain-wasting disorders often evoke a sense of fear and panic from both researchers and the general public alike. For scientists, this sense of dread stems from gaps in the knowledge base of the full pathogenesis for these diseases and a deficiency in effective treatments. What is understood, however, is the cause of wasting disorders likeRead more

Alzheimer’s Disease Linked to Loss of Epigenetic Protection

An international team of researchers has linked a gene known as peptidase M20-domain-containing protein 1 (PM20D1) with Alzheimer’s disease (AD) in humans. An analysis of genetic and epigenetic study data, combined with data from human tissue samples and subsequent experiments in mouse models, indicated that increased levels of PM20D1 in the brain have a protectiveRead more

Novel Research Model Offers Hope to ALS and MS Patients

Scientists at the Karolinska Institute in Sweden have developed a new disease model for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) that can be used to develop new immunotherapies. The model is described in a paper (“Fatal Demyelinating Disease Is Induced by Monocyte-Derived Macrophages in the Absence of TGF-β Signaling”) in NatureRead more

Human Brain Organoids Thrive in Mouse Brains

Brain organoids, also known as mini-brains, are tiny clumps of brain cells grown from stem cells that researchers are using to investigate the neural underpinnings of autism and other neurological disorders. But the organoids typically grow in culture for only a few months before they die, limiting their usefulness as models of real brains. OrganoidsRead more

Mutations in Noncoding DNA Linked to Neurodevelopmental Disorders

Pathogenic de novo mutations in coding DNA have been implicated in neurodevelopmental disorders such as developmental brain dysfunction, which can lead to impaired learning and language. In fact, according to one estimate, 42% of patients suffering these disorders carry mutations in genes that encode proteins. But it has been unclear how many patients, including patientsRead more

Pregnancy Obesity Alters Fetal Liver Epigenetics and Metabolic Pathways

Could a mother’s diet and excess weight during pregnancy predispose her offspring to become obese and develop metabolic disorders and cardiovascular diseases later in life? U.S. researchers report on new molecular and genetic studies in baboons that support existing epidemiological evidence suggesting that maternal obesity (MO) may “preprogram” offspring to develop cardiometabolic diseases in adulthoodRead more

Alzheimer’s Amyloid Gets Immune System Trim

Immune cells in the brain have a trigger, and when it is pulled, it prompts immune cells to degrade toxic β-amyloid (Aβ) proteins. This new finding, from Sanford Burnham Prebys Medical Research Institute (SBP), helps explain why a faulty trigger appears to raise the risk of Alzheimer’s disease. Increasing the genetic expression of the triggerRead more

Drinking Red Wine May Help Prevent Tooth Decay and Gum Disease

Prior research has found that drinking a glass of red wine a day may protect against cardiovascular diseases, diabetes, and neurodegenerative disorders. The latest laboratory studies by researchers in Spain now suggest that the polyphenols in red wine could also protect against the bacteria that cause tooth cavities and gum disease. The research, headed byRead more

Blood/Urine Biomarker Tests Developed for Autism Spectrum Disorders

Autsim Spectrum Disorders (ASD) are defined as developmental disorders mainly affecting social interaction and they can include a wide spectrum of behavioural problems. These include speech disturbances, repetitive and/or compulsive behaviour, hyperactivity, anxiety, and difficulty to adapt to new environments, some with or without cognitive impairment. Since there is a wide range of ASD symptomsRead more

Increasing Sirt4 Activity May Help Treat Age-Related Metabolic Decline and Disorders

Scientists report that fruit flies inhibited from producing the protein Sirt4 are short-lived, while flies modified to make extra Sirt4 are live longer. Flies lacking Sirt4 show increased sensitivity to starvation, decreased fertility and activity, and an inability to use energy stores in their bodies, add the researchers, who say their work suggests that increasing Sirt4Read more

Immune Disorder Trigger Identified

Scientists in the U.S. have identified a promising target for treating immune system-related disorders that are associated with mutations in a gene known as GTPase of immunity-associated protein 5 (Gimap5). The researchers, led by the team of Kasper Hoebe, Ph.D., at the Cincinnati Children’s Hospital Research Foundation, used inhibitors of glycogen kinase 3β (GSK3β) –Read more

Targeting Immature Myeloid Cells to Treat Inflammatory Disorders in Newborns

New research led by The Wistar Institute, in collaboration with Sun Yat-sen University in China, has characterized the transitory presence of myeloid-derived suppressor cells (MDSCs) in mouse and human newborns, revealing a critical role of these cells in regulation of inflammation in the early stages of life. Their study (“Transitory Presence of Myeloid-Derived Suppressor CellsRead more

370.00

PM 14:44•2022-01-23

Global

Address: 1 Broadway, Cambridge, MA02142 (America)

Tel: +1(626)986-9880(U.S. - West Coast)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

© 2021 © 2021 Shanghai Medicilon Inc. All rights reserved | All Rights Reserved Privacy Policy

bioanalytical testing IND Filing PROTAC API ADME Drug Discovery Animal Models Oral Solid Dosage PDX model Pharmacokinetics More